DK1189900T3 - Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler - Google Patents

Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler

Info

Publication number
DK1189900T3
DK1189900T3 DK00938160T DK00938160T DK1189900T3 DK 1189900 T3 DK1189900 T3 DK 1189900T3 DK 00938160 T DK00938160 T DK 00938160T DK 00938160 T DK00938160 T DK 00938160T DK 1189900 T3 DK1189900 T3 DK 1189900T3
Authority
DK
Denmark
Prior art keywords
melatonergic
drugs
heterocyclic
aminopyrrolidine derivatives
heterocyclic aminopyrrolidine
Prior art date
Application number
DK00938160T
Other languages
Danish (da)
English (en)
Inventor
Katherine S Takaki
Guanglin Luo
Stephen R Bertenshaw
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK1189900T3 publication Critical patent/DK1189900T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cosmetics (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK00938160T 1999-06-30 2000-06-06 Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler DK1189900T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14189499P 1999-06-30 1999-06-30
PCT/US2000/015478 WO2001002392A1 (en) 1999-06-30 2000-06-06 Heterocyclic aminopyrrolidine derivatives as melatonergic agents

Publications (1)

Publication Number Publication Date
DK1189900T3 true DK1189900T3 (da) 2004-04-26

Family

ID=22497702

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00938160T DK1189900T3 (da) 1999-06-30 2000-06-06 Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler

Country Status (13)

Country Link
US (1) US6211225B1 (es)
EP (1) EP1189900B1 (es)
JP (2) JP4767463B2 (es)
AT (1) ATE257834T1 (es)
AU (1) AU763963B2 (es)
CA (1) CA2376949C (es)
DE (1) DE60007745T2 (es)
DK (1) DK1189900T3 (es)
ES (1) ES2213022T3 (es)
PE (1) PE20010327A1 (es)
PT (1) PT1189900E (es)
UY (1) UY26226A1 (es)
WO (1) WO2001002392A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569894B1 (en) 2001-10-04 2003-05-27 Bristol-Myers Squibb Company Arylalkylbenzofuran derivatives as melatonergic agents
US6737431B2 (en) 2002-03-12 2004-05-18 Bristol-Myers Squibb Company Benzoxazole derivatives as novel melatonergic agents
CN1688527A (zh) 2002-08-12 2005-10-26 武田药品工业株式会社 稠合的苯衍生物以及用途
EP1871356A1 (en) * 2005-04-22 2008-01-02 Wyeth a Corporation of the State of Delaware Dihydrobenzofuran derivatives and uses thereof
CN101180283A (zh) * 2005-04-22 2008-05-14 惠氏公司 二氢苯并呋喃衍生物和其用途
JP2009538334A (ja) 2006-05-22 2009-11-05 ヴァンダ ファーマシューティカルズ インコーポレイテッド 抑うつ障害のための治療
CN101687810A (zh) * 2007-04-26 2010-03-31 武田药品工业株式会社 双环化合物及其药物用途
ES2331276B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuestos de fenilpirrolidina.
EP2266975A1 (en) * 2009-06-15 2010-12-29 Ferrer Internacional, S.A. 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
KR102593047B1 (ko) 2012-01-26 2023-10-24 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
BR112015012366A8 (pt) 2012-11-29 2019-10-01 Chemocentryx Inc antagonistas de cxcr7, uso dos mesmos, composição farmacêutica, bem como métodos para detectar níveis elevados de cxcr7 em uma amostra e para imagear um tumor, órgão, ou tecido
CA2893542C (en) 2012-12-18 2022-07-19 Vanda Pharmaceuticals Inc. Use of tasimelteon in the treatment of circadian rhythm disorders
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
BR112021011222A2 (pt) 2018-12-12 2021-08-24 Chemocentryx, Inc. Inibidores de cxcr7 para o tratamento de câncer
CN109574970A (zh) * 2018-12-27 2019-04-05 上海毕得医药技术有限公司 一种5-溴苯并二氢吡喃的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518273A (en) * 1966-08-03 1970-06-30 Warner Lambert Pharmaceutical Benzopyranquinolinol derivatives and process for their production
US3485835A (en) * 1968-04-10 1969-12-23 Haessle Ab 2-benzoyl-3-tertiaryamino alkoxy benzofuran derivatives
US5071875A (en) 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
FR2674524B1 (fr) 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2689124A1 (fr) 1992-03-27 1993-10-01 Adir Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5449683A (en) 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
GB9326192D0 (en) 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9407919D0 (en) 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds
FR2725985B1 (fr) 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
JP2000511518A (ja) 1996-05-14 2000-09-05 グラクソ、グループ、リミテッド 時間生物学的薬剤としてのベンゾフランおよびベンゾピラン
TW476758B (en) * 1996-12-10 2002-02-21 Bristol Myers Squibb Co Benzodioxole, benzofuran, dihydrobenzofuran and benzodioxane melatonergic agents
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ATE257834T1 (de) 2004-01-15
EP1189900A4 (en) 2002-07-31
AU763963B2 (en) 2003-08-07
WO2001002392A1 (en) 2001-01-11
EP1189900B1 (en) 2004-01-14
CA2376949C (en) 2009-05-26
AU5324000A (en) 2001-01-22
UY26226A1 (es) 2001-01-31
JP5248647B2 (ja) 2013-07-31
PE20010327A1 (es) 2001-06-10
JP4767463B2 (ja) 2011-09-07
US6211225B1 (en) 2001-04-03
DE60007745T2 (de) 2005-03-10
ES2213022T3 (es) 2004-08-16
DE60007745D1 (de) 2004-02-19
PT1189900E (pt) 2004-05-31
JP2003503492A (ja) 2003-01-28
CA2376949A1 (en) 2001-01-11
JP2011137043A (ja) 2011-07-14
EP1189900A1 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
ATE302775T1 (de) Carbolinderivate
DE60119397D1 (de) "2-Oxo-1-Pyrrolidinderivate und ihre pharmazeutische Verwendung"
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
HUP0301573A2 (hu) Szubsztituált arilpirazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE346067T1 (de) Carbolinderivate
DE60121461D1 (de) Kondensierte pyridoindolderivate
CO5210884A1 (es) DERIVADOS DE 5H-TIAZOLO[3,2-a] PIRIMIDINA
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
SE9702773D0 (sv) Novel compounds
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
TR199902848T2 (xx) Ergolin t�revleri ve bunlar�n somatostatin resept�r antagonist olarak kullan�mlar�
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DE60112960D1 (de) Kondensierte pyridoindolderivate
DE60013486D1 (de) Verbindungen
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
DE60128100D1 (de) Analgetisches arzneimittel
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
TR200200017T2 (tr) Benzofuran türevleri
CO5170443A1 (es) Derivados de coclobuten-3,4-diona,su preparacion y su aplicacion terapeutica.